Page 965 - Cardiac Nursing

LWBK340-ind_p941-958.qxd 7/1/09 10:37 AM Page 941 Aptara
LWB K34 0-i nd_ p94 1-9 58. qxd 7 / 1 / 09 10 :37 AM P a g e 94 1 A pta ra

`
˜
˜`iÝ
i
Ý
Ý
Ý

.OTE 0AGE NUMBERS FOLLOWED BY F INDICATE FIGU ES T TABLES D DISPLAY AND NCP NURSING CARE PLAN
A !CUTE CLINICALLY NONEFFUSIVE PERICARDITIS !DVANCED !6 BLOCK
F
F

!BCIXIMAB !CUTE CORONARY SYNDROMES !#3 !FTERLOAD IN MYOCARDIUM n F
FOR 0#) ALGORITHM FOR CHEST DISCOMFORT SUGGESTIVE OF !GING

FOR MYOCARDIAL INFARCTION ISCHEMIA IN F DEFINED

!BDOMEN PHYSICAL ASSESSMENT OF F CLASSIC PRESENTATION FOR PHARMACOKINETICS EFFECTS OF n
!BERRATION DEFINITION OF PHYSIOLOGIC ADAPTATIONS
MECHANISM OF n EARLY LATE AND LONG TERM CARE OF PATIENTS WITH AUTONOMIC NERVOUS SYSTEM MODULATION IN
!BNORMAL AUTOMATICITY n n n
!CCELERATED IDIOVENTRICULAR RHYTHM IMMEDIATE PATIENT MANAGEMENT n CARDIAC FUNCTIONAL CHANGES IN
!CCREDITATION #OUNCIL FOR 'RADUATE -EDICAL INITIAL EVALUATION n CARDIAC STRUCTURAL CHANGES IN n
%DUCATION !#'-% NURSING MANAGEMENT ELECTRICAL SYSTEMS IN

T
!CETYLCHOLINE T CHEST DISCOMFORT n GENERAL CHANGES IN n F
T
!CID S DECREASED SYSTEMIC PERFUSION HEPATIC CHANGES IN
BUFFERING OF n T FEAR OR ANXIETY RENAL CHANGES IN

DEFINITION OF KNOWLEDGE DEFICIT RESPIRATORY CHANGES IN n F
EXCRETION OF MYOCARDIAL TISSUE PERFUSION DECREASED VASCULAR SYSTEM IN
PRODUCTION OF n !(21 ANALYSIS
T
T
!CID BASE BALANCES n T 3EE ALSO !CID PHARMACOLOGICAL MANAGEMENT OF n !LANINE AMINOTRANSFERASE !,4 T
BASE IMBALANCES PRESENTATION OF n !LDOSTERONE

F
F

ACID BUFFERING IN n T !CUTE $ECOMPENSATE (EART &AILURE 2EGISTRY ANTAGONIST FOR HEART FAILURE F F
ACID EXCRETION IN !$(%2% DEFINITION
T
T
ACID PRODUCTION IN !CUTE EFFUSIVE PERICARDITIS FOR RENAL FLUID EGULATION T
TERMINOLOGY OF !CUTE MARGINAL BRANCH !LERT PERIOD IN PACING D
!CID BASE IMBALANCES n 3EE ALSO !CID BASE !CUTE RESPIRATORY DISTRESS SYNDROME !2$3 !LKALOSIS

F
T
F

T
F
F
BALANCES T F n F T CAUSES OF T
ARTERIAL BLOOD GAS REPORTS n !CYANOTIC HEART DEFECTS DEFINITION OF
COMPENSATION OF n COARCTATION OF AORTA n METABOLIC T

CORRECTION OF CONGENITAL AORTIC STENOSIS n F RESPIRATORY n T
METABOLIC ACIDOSIS AS n T !DENOSINE FOR ARRHYTHMIAS T !LLELES
T
METABOLIC ALKALOSIS T !DHERENCE COMPLIANCE !LLEVIATING FACTORS
T
MIXED T BEHAVIOR CHANGE !LLOPATHIC MEDICINE n
RESPIRATORY ACIDOSIS n T DEFINED !LPHA ADRENERGIC STIMULATION
RESPIRATORY ALKALOSIS n T DETERMINANTS OF !LSTRšM SYNDROME n
VASCULAR EFFECTS OF T PATIENT RELATED !LTERNATIVE MEDICINE 3EE #OMPLEMENTARY AND
!CIDOSIS PROVIDER RELATED ALTERNATIVE MEDICINE #!-
DEFINITION OF REGIMEN RELATED !MERICAN #OLLEGE OF #ARDIOLOGY !##
T
T
METABOLIC AS n T SYSTEM RELATED n GUIDELINES FOR !& THERAPY Tn T
RESPIRATORY n T EDUCATIONAL STRATEGY FOR GUIDELINES FOR ECHOCARDIOGRAPHY
T
T

!CQUIRED VALVULAR HEART DISEASE QUESTIONNAIRES FOR n GUIDELINES FOR !#3 T F
CAUSES THERAPEUTIC RELATIONSHIP FOR GUIDELINES FOR IMPLANTABLE CARDIOVERTER
D
D
INEFFECTIVE ENDOCARDITIS n MEASUREMENT OF n T DEFIBRILLATOR THERAPY Dn D
MISCELLANEOUS BIOLOGIC GUIDELINES FOR MYOCARDIAL INFARCTION
RHEUMATIC HEART DISEASE DIARIES IN n GUIDELINES FOR REPERFUSION STRATEGY T
EPIDEMIOLOGY ELECTRONIC MONITORING n GUIDELINES FOR SELECTING REPERFUSION STRATEGY
SYSTOLIC MURMURS RELATED TO n METHODS T D
!CTION POTENTIALS PHARMACY REFILLS !MERICAN (EART !SSOCIATION !(!
T
T

OF ATRIAL CELLS PILL COUNT GUIDELINES FOR !#3 T F
T
T
OF ATRIOVENTRICULAR NODE QUESTIONNAIRES GUIDELINES FOR !& THERAPY Tn T
OF BUNDLE OF HIS SELF REPORT MEASURE n GUIDELINES USING LEVEL OF %VIDENCE CRITERIA
PROPERTIES OF T PREVENTING MONITORING AND ADDRESSING D
DEFINED PROBLEMS OF D GUIDELINES FOR IMPLANTABLE CARDIOVERTER
D
D
OF MYOCARDIAL CELLS n STRATEGIES FOR ENHANCING n T DEFIBRILLATOR THERAPY Dn D
OF 0URKINJE TYPE CELLS VS NONADHERENCE n GUIDELINES FOR PRIMARY 0#) FOR 34%-)

REFRACTORY PERIODS n F !DULT !DVANCED #ARDIAC ,IFE 3UPPORT !#,3 n
OF SINUS NODE CELLS n n GUIDELINES FOR REPERFUSION STRATEGY T
!CTIVATED #LOTTING 4IME !#4 T T CARDIAC MANAGEMENT ALGORITHM FOR n !MINO ACIDS DEFINITION O D
T
T
T
T
EARLY DEFIBRILLATION FO n !MIODARONE
!CTIVATED PARTIAL THROMBOPLASTIN TIME A044 ELECTRICAL THERAPY OF MALIGNANT ARRHYTHMIAS IN AS ANTIARRHYTHMIC DRUGS T
F
F
F T n FOR ANTIARRHYTHMIC THERAPY

T
T
!CTIVITIES !DULT 4REATMENT 0ANEL ))) !40 ))) FOR ARRHYTHMIAS T
METABOLIC EQUIVALENTS D CLASSIFICATIO FOR CARDIAC ARREST D
D
D
PHYSICAL 3EE %XERCISE OF ,$, CHOLESTEROL D T MANAGEMENT OF !& AND ATRIAL FLUTTE T
AND STERNAL PRECAUTIONS AND GUIDELINES OF D OF TRIGLYCERIDES T SCIENTIFIC EVIDENCE FOR USE OF D

!CUPUNCTURE F MODIFICATION BASED ON T !MYLIN ANALOGS
941